The legacy of the blue pill offers a intricate case study for analysts eyeing drug companies. While initial sales were explosive, current patent lapse and the arrival of generic versions have considerably affected https://antonuiay994613.dm-blog.com/41330499/the-blue-pill-and-the-pharmaceutical-industry-a-risky-bet